Kálium-Jodid Ep

Potassium Iodide, the active ingredient in Kálium-Jodid Ep, is a iodine compound presented as an oral preparation for oral use. It provides stable iodine to saturate the thyroid gland, thereby blocking uptake of radioactive iodine in individuals at risk of radiation exposure. GNH USA supplies Kálium-Jodid Ep as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kálium-Jodid Ep is used to protect the thyroid gland by providing stable iodine in situations of radioactive iodine exposure. - Radiation emergency preparedness: supplies the thyroid with stable iodine to reduce radioactive iodine uptake. - Nuclear incident response: serves as a prophylactic measure for populations near nuclear facilities after a release. - Thyroid blockade before radioiodine therapy: helps limit thyroid exposure during diagnostic or therapeutic radioiodine procedures.

Potassium Iodide may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea or vomiting - Metallic taste in the mouth - Mild abdominal discomfort or diarrhea - Headache

Serious or Rare Side Effects: - Allergic reaction such as rash or urticaria - Swelling of the face, lips, or tongue - Difficulty breathing or wheezing - Thyroid dysfunction (hypo‑ or hyper‑thyroidism) - Hyperkalemia in susceptible individuals

When considering Potassium Iodide, several safety measures should be observed. - Pregnancy: consult a physician; limited safety data are available. - Breastfeeding: evaluate risk versus benefit before use. - Kidney impairment: monitor serum potassium levels closely. - Existing thyroid disease: assess necessity and dosage carefully. - Drug interactions: review all concomitant medications with a healthcare professional. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture.

Potassium Iodide can interact with several medications, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Thyroid hormone therapy: may diminish the intended blockade effect. - Lithium: can potentiate thyroid suppression. - ACE inhibitors: increased risk of hyperkalemia.

Moderate Interactions (Monitor Closely): - Diuretics (especially potassium‑sparing): monitor serum potassium. - Amiodarone: watch for altered thyroid function.